Increased TNF-α and IL-1 secretion from AMs of patients with lung cancer after stimulation with IFN-γ and granulocyte-macrophage colony-stimulating factor (GM-CSF) has been demonstrated in comparison with patients with nonmalignant disorders [7]. This evidence concerns the gene CSF2 and lung cancer.